KNC nanozyme repairs hypoxia ischemia brain damage through ALOX12 mediated lipid peroxidation inhibition.
- DOI
- 10.1016/j.bioactmat.2025.08.032
- Published
- 2025-09-02
- Container
- Bioact Mater
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioactmat.2025.08.032,
title = {KNC nanozyme repairs hypoxia ischemia brain damage through ALOX12 mediated lipid peroxidation inhibition.},
author = {Dong X and Jiang D and Chen S and Tan J and Zhao J and Liu X and Lu Z and Yeung KWK and Liao Y and Liu X and Ouyang L.},
year = {2025},
journal = {Bioact Mater},
doi = {10.1016/j.bioactmat.2025.08.032},
url = {https://doi.org/10.1016/j.bioactmat.2025.08.032}
}RIS
TY - JOUR TI - KNC nanozyme repairs hypoxia ischemia brain damage through ALOX12 mediated lipid peroxidation inhibition. AU - Dong X AU - Jiang D AU - Chen S AU - Tan J AU - Zhao J AU - Liu X AU - Lu Z AU - Yeung KWK AU - Liao Y AU - Liu X AU - Ouyang L. PY - 2025 JO - Bioact Mater DO - 10.1016/j.bioactmat.2025.08.032 UR - https://doi.org/10.1016/j.bioactmat.2025.08.032 ER -
APA
X, D., D, J., S, C., J, T., J, Z., X, L., Z, L., KWK, Y., Y, L., X, L., & L., O. (2025). KNC nanozyme repairs hypoxia ischemia brain damage through ALOX12 mediated lipid peroxidation inhibition.. Bioact Mater. https://doi.org/10.1016/j.bioactmat.2025.08.032
Source records
- europe-pmc · retrieved 2026-09-27T08:08:14.197Z